These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 25711069)

  • 1. [Tafluprost--a novel prostaglandin F2alpha analogue].
    Petrov SIu
    Vestn Oftalmol; 2014; 130(5):85-95. PubMed ID: 25711069
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy and safety levels of preserved and preservative-free tafluprost are equivalent in patients with glaucoma or ocular hypertension: results from a pharmacodynamics analysis.
    Hamacher T; Airaksinen J; Saarela V; Liinamaa MJ; Richter U; Ropo A
    Acta Ophthalmol Suppl (Oxf ); 2008; 242():14-9. PubMed ID: 18752510
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IOP-lowering efficacy and tolerability of preservative-free tafluprost 0.0015% among patients with ocular hypertension or glaucoma.
    Hommer A; Mohammed Ramez O; Burchert M; Kimmich F
    Curr Med Res Opin; 2010 Aug; 26(8):1905-13. PubMed ID: 20553122
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics, efficacy and safety profiles of preserved and preservative-free tafluprost in healthy volunteers.
    Uusitalo H; Kaarniranta K; Ropo A
    Acta Ophthalmol Suppl (Oxf ); 2008; 242():7-13. PubMed ID: 18752509
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Optimization of benzalkonium chloride concentration in 0.0015% tafluprost ophthalmic solution from the points of ocular surface safety and preservative efficacy].
    Asada H; Takaoka-Shichijo Y; Nakamura M; Kimura A
    Yakugaku Zasshi; 2010 Jun; 130(6):867-71. PubMed ID: 20519865
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of changing from preserved prostaglandins to preservative-free tafluprost in patients with glaucoma on tear film thickness.
    Hommer A; Schmidl D; Kromus M; Bata AM; Fondi K; Werkmeister RM; Baar C; Schmetterer L; Garhöfer G
    Eur J Ophthalmol; 2018 Jul; 28(4):385-392. PubMed ID: 29592773
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preservative-free tafluprost 0.0015% in the treatment of patients with glaucoma and ocular hypertension.
    Erb C; Lanzl I; Seidova SF; Kimmich F
    Adv Ther; 2011 Jul; 28(7):575-85. PubMed ID: 21725844
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro effects of preservative-free tafluprost and preserved latanoprost, travoprost, and bimatoprost in a conjunctival epithelial cell line.
    Brasnu E; Brignole-Baudouin F; Riancho L; Guenoun JM; Warnet JM; Baudouin C
    Curr Eye Res; 2008 Apr; 33(4):303-12. PubMed ID: 18398704
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Corneal penetration into rabbit aqueous humor is comparable between preserved and preservative-free tafluprost.
    Pellinen P; Lokkila J
    Ophthalmic Res; 2009; 41(2):118-22. PubMed ID: 19147999
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Switching from a preserved to a preservative-free prostaglandin preparation in topical glaucoma medication.
    Uusitalo H; Chen E; Pfeiffer N; Brignole-Baudouin F; Kaarniranta K; Leino M; Puska P; Palmgren E; Hamacher T; Hofmann G; Petzold G; Richter U; Riedel T; Winter M; Ropo A
    Acta Ophthalmol; 2010 May; 88(3):329-36. PubMed ID: 20546237
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of benzalkonium chloride-preserved, polyquad-preserved, and sofZia-preserved topical glaucoma medications on human ocular epithelial cells.
    Ammar DA; Noecker RJ; Kahook MY
    Adv Ther; 2010 Nov; 27(11):837-45. PubMed ID: 20931366
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tafluprost: the first preservative-free prostaglandin to treat open-angle glaucoma and ocular hypertension.
    Swymer C; Neville MW
    Ann Pharmacother; 2012 Nov; 46(11):1506-10. PubMed ID: 23092867
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Randomized clinical trial of the efficacy and safety of preservative-free tafluprost and timolol in patients with open-angle glaucoma or ocular hypertension.
    Chabi A; Varma R; Tsai JC; Lupinacci R; Pigeon J; Baranak C; Noble L; Lines C; Ho TW
    Am J Ophthalmol; 2012 Jun; 153(6):1187-96. PubMed ID: 22310086
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanisms of benzalkonium chloride toxicity in a human trabecular meshwork cell line and the protective role of preservative-free tafluprost.
    Chang C; Zhang AQ; Kagan DB; Liu H; Hutnik CM
    Clin Exp Ophthalmol; 2015 Mar; 43(2):164-72. PubMed ID: 25041649
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tafluprost: a novel prostaglandin analog for treatment of glaucoma.
    Pantcheva MB; Seibold LK; Awadallah NS; Kahook MY
    Adv Ther; 2011 Sep; 28(9):707-15. PubMed ID: 21858491
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Real advantages of preservative-free preparations in special containers for long-term glaucoma therapy.
    Boles Carenini B; Boldrini E; Brogliatti B
    Acta Ophthalmol Scand Suppl; 2002; 236():57-9. PubMed ID: 12390147
    [No Abstract]   [Full Text] [Related]  

  • 17. [Corneal sensitivity in patients treated medically for glaucoma or ocular hypertension].
    Van Went C; Alalwani H; Brasnu E; Pham J; Hamard P; Baudouin C; Labbé A
    J Fr Ophtalmol; 2011 Dec; 34(10):684-90. PubMed ID: 22093372
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tafluprost for glaucoma.
    Papadia M; Bagnis A; Scotto R; Traverso CE
    Expert Opin Pharmacother; 2011 Oct; 12(15):2393-401. PubMed ID: 21916788
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapeutic uses of prostaglandin F(2α) analogues in ocular disease and novel synthetic strategies.
    Dams I; Wasyluk J; Prost M; Kutner A
    Prostaglandins Other Lipid Mediat; 2013; 104-105():109-21. PubMed ID: 23353557
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Meibomian gland dropout rate as a method to assess meibomian gland morphologic changes during use of preservative-containing or preservative-free topical prostaglandin analogues.
    Lee SY; Lee K; Park CK; Kim S; Bae HW; Seong GJ; Kim CY
    PLoS One; 2019; 14(6):e0218886. PubMed ID: 31242247
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.